[ad_1] Morris Sherman, MD In the past 18 months, three drugs have been approved in the United States for the treatment of patients with hepatocellular carcinoma (HCC), with additional targeted therapies and …
Read More »ILCA President Highlights Progress and Plans for the Future of HCC Treatment
